Correlations between 18F-FDG uptake by bone marrow and hematological parameters: measurements by PET/CT

Nuclear Medicine and Biology

Volumn 33, Issue 8, 2006, Pages 999-1004

  Murata, Yuji ^a   Kubota, Kazuo ^b   Yukihiro, Masashi ^b   Ito, Kimiteru ^b   Watanabe, Hiroshige ^a   Shibuya, Hitoshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Blood cell; Bone marrow; FDG; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; HEMOPOIETIC GROWTH FACTOR; TRACER; COLONY STIMULATING FACTOR 1; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 3;

ADULT; ARTICLE; BONE MARROW; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG UPTAKE; ERYTHROCYTE COUNT; FEMALE; GRANULOCYTE PRECURSOR; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; NEUTROPHIL COUNT; THREE DIMENSIONAL IMAGING; THROMBOCYTE COUNT; AGED; BLOOD CELL COUNT; COMPUTER ASSISTED TOMOGRAPHY; GLUCOSE BLOOD LEVEL; METABOLISM; METHODOLOGY; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; REGRESSION ANALYSIS;

ADULT; AGED; BLOOD CELL COUNT; BLOOD GLUCOSE; BONE MARROW; FEMALE; FLUORODEOXYGLUCOSE F18; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-3; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; REGRESSION ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33751225641     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2006.09.005     Document Type: Article

References (21)

1. Cook G.J., Maisey M.N., and Fogelman I. Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine. Eur J Nucl Med 26 (1999) 1363-1378
2. Chiang S.B., Rebenstock A., Guan L., Alavi A., and Zhuang H. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging. Clin Nucl Med 28 (2003) 674-676
3. Elstrom R.L., Tsai D.E., Vergilio J.A., Downs L.H., Alavi A., and Schuster S.J. Enhanced marrow [18F]fluorodeoxyglucose uptake related to myeloid hyperplasia in Hodgkin's lymphoma can simulate lymphoma involvement in marrow. Clin Lymphoma 5 (2004) 127
4. Yao W.J., Hoh C.K., Hawkins R.A., Glaspy J.A., Weil J.A., Lee S.J., et al. Quantitative PET imaging of bone marrow glucose metabolic response to hematopoietic cytokines. J Nucl Med 36 (1995) 794-799
5. Knopp M.V., Bischoff H., Rimac A., Oberdorfer F., and van Kaick G. Bone marrow uptake of fluorine-18-fluorodeoxyglucose following treatment with hematopoietic growth factors: initial evaluation. Nucl Med Biol 23 (1996) 845-849
6. Sugawara Y., Fisher S.J., Zasodny K.R., Kison P.V., Baker L.H., and Wahl R.L. Preclinical and clinical studies of bone marrow uptake of fluorine-18-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy. J Clin Oncol 16 (1998) 173-180
7. Hollinger E.F., Alibazoglu H., Ali A., Green A., and Lamonica G. Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging. Clin Nucl Med 23 (1998) 93-98
8. Lee G.R., Bithell T.C., Foerster J., Athens J.W., and Lukens J.N. Wintrobe's clinical hematology. 9th ed. (1983), Lea and Febiger, Philadelphia, PA 70
9. Ramalho A.T., Curado M.P., and Natarajan A.T. Lifespan of human lymphocytes estimated during a six year cytogenetic follow-up of individuals accidentally exposed in the 1987 radiological accident in Brazil. Mutat Res 331 (1995) 47-54
10. Hamilton J.A., Vairo G., and Lingelbach S.R. CSF-1 stimulates glucose uptake in murine bone marrow-derived macrophages. Biochem Biophys Res Commun 138 (1986) 445-454
11. Hamilton J.A., Vairo G., and Lingelbach S.R. Activation and proliferation signals in murine macrophages: stimulation of glucose uptake by hemopoietic growth factors and other agents. J Cell Physiol 134 (1988) 405-412
12. Berridge M.V., and Tan A.S. Interleukin-3 facilitates glucose transport in a myeloid cell line by regulating the affinity of the glucose transporter for glucose: involvement of protein phosphorylation in transporter activation. Biochem J 305 (1995) 843-851
13. Ahmed N., and Berridge M.V. Regulation of glucose transport by interleukin-3 in growth factor-dependent and oncogene-transformed bone marrow-derived cell lines. Leuk Res 21 (1997) 609-618
14. McCoy K.D., Ahmed N., Tan A.S., and Berridge M.V. The hemopoietic growth factor, interleukin-3, promotes glucose transport by increasing the specific activity and maintaining the affinity for glucose of plasma membrane glucose transporters. J Biol Chem 272 (1997) 17276-17282
15. Ahmed N., and Berridge M.V. Distinct regulation of glucose transport by interleukin-3 and oncogenes in a murine bone marrow-derived cell lines. Biochem Pharmacol 57 (1999) 387-396
16. Ogawa M. Differentiation and proliferation of hematopoietic cells. Blood 81 (1993) 2844-2853
17. Ghosal J., Chakraborty C., Biswas T., Ganguly C.K., and Datta A.G. Effect of erythropoietin on the glucose transport of rat erythrocytes and bone marrow cells. Biochem Med Metab Biol 38 (1987) 134-141
18. Billat C., and Jacquot R. Glucose uptake by rat erythroid cells: the effects of erythropoietin and dexamethasone. Exp Hematol 20 (1992) 925-929
19. Kim H.D., Koury M.J., Lee S.J., Im J.H., and Sawyer S.T. Metabolic adaptation during erythropoietin-mediated terminal differentiation of mouse erythroid cells. Blood 77 (1991) 387-392
20. Plantade A., Montravers F., Selle F., Izrael V., and Talbot J.N. Diffusely increased F-18 FDG uptake in bone marrow in a patient with acute anemia and recent erythropoietin therapy. Clin Nucl Med 28 (2003) 771-772
21. Blodgett T.M., Ames J.T., Torok F.S., McCook B.M., and Meltzer C.C. Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin. Clin Nucl Med 29 (2004) 161-163